AtriCure, Inc. (ATRC) research
AtriCure, Inc.- Sector
- Health Care
- Last price
- $58.83
- As of
AtriCure, Inc. (ATRC): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-07-27.
As of . Source: SEC EDGAR filings for ATRC. Method and limitations.
Share the ATRC intelligence card
See ATRC live in the terminal
Track ATRC's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live ATRC terminal, freeActive signals for ATRC
- highCONSENSUS_BUY
5 tracked funds increased ATRC this 2026Q2, institutional consensus
- highCONSENSUS_BUY
3 tracked funds increased ATRC this 2026Q2, institutional consensus
- highINSTITUTIONAL_SURGE
Point72 Asset Management, L.P. added +117% to ATRC (2026Q2)
- highINSTITUTIONAL_EXIT
CITADEL ADVISORS LLC cut 92% of ATRC (2026Q2)
- highINSTITUTIONAL_SURGE
D. E. Shaw & Co., Inc. added +241% to ATRC (2026Q2)
FREE, NO ACCOUNT
Every signal on ATRC, as it fires
You are seeing 5 of 29 signals recorded on ATRC since 2026-05-31.
The five above landed across 2 days. The other 24 were recorded on 3 other days. 18 of the 29 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in ATRC (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P.CUSIP 04963C209 · 2026Q2 | $16.9M | 0.02% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 04963C209 · 2026Q2 | $14.7M | 0.01% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 04963C209 · 2026Q2 | $6.6M | 0.01% | , |
| D. E. Shaw & Co., Inc.CUSIP 04963C209 · 2026Q2 | $5.4M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 04963C209 · 2026Q2 | $5M | 0.00% | , |
| Bridgewater Associates, LPCUSIP 04963C209 · 2026Q2 | $2.1M | 0.01% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, ATRC
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
ATRC against its peers
ATRC's operating margin of -1.8% ranks in the 19th percentile of 23 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-03-31.
| Metric | ATRC | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 535M USD | 1.5B USD | 10 | 25 |
| Gross margin | 75.0% | 56.2% | 88 | 19 |
| Operating margin | -1.8% | 6.6% | 19 | 23 |
| Net margin | -2.1% | 3.7% | 33 | 25 |
| Return on equity | -2.3% | 7.0% | 30 | 24 |
| P / E | n/a | 34.4x | n/a | 15 |
Peers (25): AVAH, TMDX, WGS, BKD, ACHC, PRVA, CRVL, IRTC, OPCH, NVST, INSP, ALHC, MD, PGNY, SEM, LIVN, ITGR, XRAY, NVCR, DOCS, LMAT, WAY, HAE, MMSI, TFX. Fiscal periods ending between 2025-12-31 and 2026-03-31. Every figure is one full fiscal year read from one annual filing (ATRC: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more ATRC signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to ATRCand get the insider, 13F, options, and confluence read in one view.